Kerrie L Moreau1, Brian L Stauffer, Wendy M Kohrt, Douglas R Seals. 1. PhD, AssociateDivision of Geriatric Medicine, University of Colorado School of Medicine, Building L15, Room 8111, 12631 East 17th Avenue, PO Box 6511, Aurora, CO 80045. Kerrie.Moreau@ucdenver.edu.
Abstract
OBJECTIVE: In contrast to age-matched men, endurance exercise training is not consistently associated with enhanced endothelial function in estrogen-deficient postmenopausal women. We determined whether endurance exercise training improves endothelial function in postmenopausal women treated with estrogen. In a substudy, we determined if oxidative stress is mechanistically linked to endothelial function adaptations to endurance exercise training. PARTICIPANTS AND DESIGN:Brachial artery flow-mediated dilation (FMD) was measured in 36 sedentary, estrogen-deficient postmenopausal women (45-65 y) at study entry (baseline), after 12 weeks of eitherplacebo, oral (1 mg/d) estradiol, or transdermal estradiol (0.05 mg/d) (randomized), and after an additional 12 weeks of continued estradiol or placebo treatment with concurrent endurance exercise training. In subgroups of women, FMD also was measured during the infusion of ascorbic acid at baseline and following estradiol/placebo plus endurance exercise training, and in seven habitually endurance-trained estrogen-deficient controls. RESULTS:FMD increased in the estrogen-treated groups (both P < .01) after 12 weeks and remained unchanged in placebo. FMD further increased following 12 weeks of endurance exercise training in estrogen-treated (both P < .025), but not placebo-treated women (P = .55). In the substudy, baseline FMD was similar between sedentary and endurance-trained controls. Ascorbic acid increased FMD at baseline in sedentary women and endurance-trained controls, and following endurance exercise training in placebo-treated, but not in estrogen-treated women. CONCLUSIONS: Estrogen status appears to play an important modulatory role in improvements in endothelial function with endurance exercise training in postmenopausal women. The restored endurance exercise training adaptation in estrogen-treated postmenopausal women may be related to mitigation of oxidative stress.
RCT Entities:
OBJECTIVE: In contrast to age-matched men, endurance exercise training is not consistently associated with enhanced endothelial function in estrogen-deficient postmenopausal women. We determined whether endurance exercise training improves endothelial function in postmenopausal women treated with estrogen. In a substudy, we determined if oxidative stress is mechanistically linked to endothelial function adaptations to endurance exercise training. PARTICIPANTS AND DESIGN: Brachial artery flow-mediated dilation (FMD) was measured in 36 sedentary, estrogen-deficient postmenopausal women (45-65 y) at study entry (baseline), after 12 weeks of either placebo, oral (1 mg/d) estradiol, or transdermal estradiol (0.05 mg/d) (randomized), and after an additional 12 weeks of continued estradiol or placebo treatment with concurrent endurance exercise training. In subgroups of women, FMD also was measured during the infusion of ascorbic acid at baseline and following estradiol/placebo plus endurance exercise training, and in seven habitually endurance-trained estrogen-deficient controls. RESULTS:FMD increased in the estrogen-treated groups (both P < .01) after 12 weeks and remained unchanged in placebo. FMD further increased following 12 weeks of endurance exercise training in estrogen-treated (both P < .025), but not placebo-treated women (P = .55). In the substudy, baseline FMD was similar between sedentary and endurance-trained controls. Ascorbic acid increased FMD at baseline in sedentary women and endurance-trained controls, and following endurance exercise training in placebo-treated, but not in estrogen-treated women. CONCLUSIONS: Estrogen status appears to play an important modulatory role in improvements in endothelial function with endurance exercise training in postmenopausal women. The restored endurance exercise training adaptation in estrogen-treated postmenopausal women may be related to mitigation of oxidative stress.
Authors: Paula J Harvey; Peter E Picton; Winnie S Su; Beverley L Morris; Catherine F Notarius; John S Floras Journal: Am Heart J Date: 2005-02 Impact factor: 4.749
Authors: Magnus Hagmar; Maria J Eriksson; Caroline Lindholm; Karin Schenck-Gustafsson; Angelica Lindén Hirschberg Journal: Clin J Sport Med Date: 2006-05 Impact factor: 3.638
Authors: Cristiana Vitale; Giuseppe Mercuro; Elena Cerquetani; Giuseppe Marazzi; Roberto Patrizi; Francesco Pelliccia; Maurizio Volterrani; Massimo Fini; Peter Collins; Giuseppe M C Rosano Journal: Arterioscler Thromb Vasc Biol Date: 2007-12-06 Impact factor: 8.311
Authors: Quan-Jiang Zhang; Shawna L McMillin; Jason M Tanner; Milda Palionyte; E Dale Abel; J David Symons Journal: J Physiol Date: 2009-06-08 Impact factor: 5.182
Authors: Daniel J Green; Maria T E Hopman; Jaume Padilla; M Harold Laughlin; Dick H J Thijssen Journal: Physiol Rev Date: 2017-04 Impact factor: 37.312
Authors: Yasina B Somani; James A Pawelczyk; Mary Jane De Souza; Penny M Kris-Etherton; David N Proctor Journal: Am J Physiol Heart Circ Physiol Date: 2019-06-07 Impact factor: 4.733
Authors: Cemal Ozemek; Kerry L Hildreth; Patrick J Blatchford; K Joseph Hurt; Rachael Bok; Douglas R Seals; Wendy M Kohrt; Kerrie L Moreau Journal: J Appl Physiol (1985) Date: 2020-03-05
Authors: Megan M Wenner; Kelly N Sebzda; Andrew V Kuczmarski; Ryan T Pohlig; David G Edwards Journal: Am J Physiol Regul Integr Comp Physiol Date: 2017-04-24 Impact factor: 3.619